Press Release - A drug currently approved for smallpox in the U.S. will undergo clinical trials to treat patients infected by the Mpox viruswho are at risk of severe complications in the Democratic ...

The trial will be conducted in the Democratic Republic of the Congo in partnership with Emergent BioSolutions.

The Africa Centre Disease Control (CDC), with global health partners, has announced the launch of a "pivotal" clinical trial ...

Emergent BioSolutions (EBS) announced that brincidofovir will be included in a clinical trial conducted and sponsored by Panther, under the ...

PANTHER to conduct clinical trial under the leadership of Africa Centres for Disease Control and PreventionGAITHERSBURG, Md., Nov. 06, 2024 ...

Emergent Biosolutions (EBS) stock rose 14% post-market after the company raised the lower end of its revenue guidance range ...

Inventus Mining Corp. (TSX VENTURE: IVS) ("Inventus” or the "Company”) is pleased to report that it has closed the previously announced non-brokered private placement of 15,000,000 units of the ...

A council plans on battling “the plague” of shopping trolleys dumped in its rivers and streets by hitting supermarkets harder in the pocket. A wildlife reserve visitor centre has been damaged ...